The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 7,855 | 187,500 | SH | SOLE | 187,500 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,023 | 72,500 | SH | SOLE | 72,500 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 1,711 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 5,303 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 6,885 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 1,545 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 2,058 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 2,392 | 234,179 | SH | SOLE | 234,179 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,190 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,190 | 15,000 | SH | Put | SOLE | 15,000 | 0 | 0 | |
| EPIZYME INC | COM | 29428V104 | 3,482 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 4,598 | 239,500 | SH | SOLE | 239,500 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 7,277 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 3,611 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 7,134 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 2,033 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 3,625 | 72,500 | SH | SOLE | 72,500 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 6,954 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 472 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 2,220 | 179,029 | SH | SOLE | 179,029 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 6,885 | 228,500 | SH | SOLE | 228,500 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 1,958 | 65,000 | SH | Call | SOLE | 65,000 | 0 | 0 | |
| SPARK THERAPEUTICS INC | COM | 84652J103 | 8,309 | 162,500 | SH | SOLE | 162,500 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 1,622 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 908 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 1,681 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 3,544 | 322,500 | SH | SOLE | 322,500 | 0 | 0 | ||